Search - tctmd.com

Displaying 201 - 220 of 257

Sort: Relevancy | Date

News Daily News

Refined Approach to Pulmonary Angioplasty Leads to Better Outcomes

Caitlin E. Cox

December 02, 2012

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Daily News

Dabigatran Usage up, Both for A-fib and Off-Label Indications

September 12, 2012

News Daily News

Meta-analysis Takes an Indirect Look at Differences Among Novel Anticoagulants

September 11, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Daily News

Indirect Comparisons Show Little Difference Among New Anticoagulants

August 14, 2012

News Daily News

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

Yael L. Maxwell

August 09, 2012

News Daily News

Antiplatelet Shows Promise for Secondary Prevention in PAD

Caitlin E. Cox

June 25, 2012

News Daily News

RE-LY: Dabigatran Shortens Drug Interruption with No Increased Bleeding

Jason Kahn

June 22, 2012

News Daily News

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

June 05, 2012

News Daily News

Risk of Intracranial Hemorrhage, Mortality Lower with Dabigatran in A-fib Patients

L.A. McKeown

April 30, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

L.A. McKeown

March 24, 2012

News Daily News

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

March 22, 2012

News Daily News

OCT Shows Modest Ability to Identify Hemodynamically Severe Lesions

L.A. McKeown

March 15, 2012

Advertisement

Refined Approach to Pulmonary Angioplasty Leads to Better Outcomes

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Evidence Continues to Support Dabigatran Treatment in A-fib

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

Dabigatran Usage up, Both for A-fib and Off-Label Indications

Meta-analysis Takes an Indirect Look at Differences Among Novel Anticoagulants

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Indirect Comparisons Show Little Difference Among New Anticoagulants

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

Antiplatelet Shows Promise for Secondary Prevention in PAD

RE-LY: Dabigatran Shortens Drug Interruption with No Increased Bleeding

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

Risk of Intracranial Hemorrhage, Mortality Lower with Dabigatran in A-fib Patients

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

OCT Shows Modest Ability to Identify Hemodynamically Severe Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content